Long–Term Oncologic Outcomes After Isolated Limb Infusion for Locoregionally Metastatic Melanoma: An International Multicenter Analysis | Zendy

John T. Miura | Zendy; Hidde M. Kroon | Zendy; Georgia M. Beasley | Zendy; Dean Mullen | Zendy; Norma E. Farrow | Zendy; Paul J. Mosca | Zendy; Michael Lowe | Zendy; Clara R. Farley | Zendy; Youngchul Kim | Zendy; Syeda Mahrukh Hussnain Naqvi | Zendy; Aishwarya Potdar | Zendy; Hala Daou | Zendy; James Sun | Zendy; Jeffrey M. Farma | Zendy; Michael A. Henderson | Zendy; David Speakman | Zendy; Jonathan W. Serpell | Zendy; Keith A. Delman | Zendy; B. Mark Smithers | Zendy; Brendon J. Coventry | Zendy; Douglas S. Tyler | Zendy; John F. Thompson | Zendy; Jonathan S. Zager | Zendy

Open Access

Long–Term Oncologic Outcomes After Isolated Limb Infusion for Locoregionally Metastatic Melanoma: An International Multicenter Analysis

Author(s) -

John T. Miura,

Hidde M. Kroon,

Georgia M. Beasley,

Dean Mullen,

Norma E. Farrow,

Paul J. Mosca,

Michael Lowe,

Clara R. Farley,

Youngchul Kim,

Syeda Mahrukh Hussnain Naqvi,

Aishwarya Potdar,

Hala Daou,

James Sun,

Jeffrey M. Farma,

Michael A. Henderson,

David Speakman,

Jonathan W. Serpell,

Keith A. Delman,

B. Mark Smithers,

Brendon J. Coventry,

Douglas S. Tyler,

John F. Thompson,

Jonathan S. Zager

Publication year - 2019

Publication title -

annals of surgical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.764

H-Index - 173

eISSN - 1534-4681

pISSN - 1068-9265

DOI - 10.1245/s10434-019-07288-w

Subject(s) - medicine , surgical oncology , stage (stratigraphy) , melanoma , surgery , perioperative , paleontology , cancer research , biology

Isolated limb infusion (ILI) is a minimally invasive procedure for delivering high-dose regional chemotherapy to patients with locally advanced or in-transit melanoma located on a limb. The current international multicenter study evaluated the perioperative and long-term oncologic outcomes for patients who underwent ILI for stage 3B or 3C melanoma.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research